Coherus Oncology Inc (CHRS)

Total Costs & Expenses

$46.64M

Quarterly · Period ending: · USD

CHRS logo

CHRS Total Costs & Expenses

Latest reported$46.64M
CHRS Quarterly Total Costs & Expenses ($9.37M → $46.64M)
High-resolution chart · PNG

CHRS total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
46,638,000
48,461,000
58,628,000
53,804,000
55,740,000
53,034,000
96,390,000
77,161,000
85,488,000
70,095,000
160,429,000
106,574,000
93,259,000
100,181,000
96,845,000
125,873,000
104,164,000
141,040,000
112,918,000
115,290,000
111,807,000
250,394,000
93,994,000
79,835,000
70,364,000
75,312,000
78,823,000
59,843,000
55,940,000
53,697,000
60,502,000
56,972,000
44,910,000
42,032,000
46,466,000
56,615,000
58,033,000
72,578,000
74,304,000
78,218,000
76,804,000
76,711,000
62,405,000
78,384,000
65,761,000
42,558,000
33,053,000
22,475,000
22,903,000
17,357,000
11,719,000
7,289,000
9,216,000
9,368,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.